LUTS Identified As Risk Factor for Falls
ORLANDO—Elderly men with moderate or severe lower urinary tract symptoms (LUTS) are at significantly greater risk for falls, and the risk dramatically increases as the symptoms worsen, data show.
Print Issue: August 01, 2008
Lower BP Goal in Black CKD Patients
NEW ORLEANS—An extended follow-up of patients in the African American Study of Kidney Disease (AASK) confirms that ACE inhibitors work better than amlodipine in treating nondiabetic hypertensive CKD in black patients.
Prostate Cancer Patient Sues Over Late Diagnosis
For more than 30 years, most of the patients in Dr. R’s thriving primary care practice had been of retirement age. Now that he was 62, they were his contemporaries. Dr. R treated patients the way that he wanted to be treated— with respect and without unnecessary tests.
Insurers Should Cover Post-Op ED Treatment
ORLANDO—Men who experience erectile dysfunction (ED) following prostate cancer surgery usually do not have coverage for ED treatment even though their insurance policies cover surgery for prostate cancer, according to a study.
Integrated Meter/Pump System Okayed for Insulin Delivery
Animas Corporation of West Chester, Pa., has received clearance for its OneTouch Ping Glucose Management System, with the first full-feature insulin pump that wirelessly communicates with a blood glucose meter-remote.
Warning Added to Labeling of Diabetic Ulcer Cream
The FDA announced the addition of a boxed warning to the label of Regranex Gel 0.01% (becaplermin), a topical cream indicated for treatment of non-healing leg and foot ulcers in diabetic patients.
Compact, Coding-Free Glucose Monitor Cleared
Arkray USA, Inc., of Edina, Minn., has been cleared by the FDA to market its Glucocard 01 Blood Glucose Monitoring System, which requires no coding, displays results in seven seconds, and requires a tiny 0.3-microliter sample size.
New Indication for Combo to Treat Enlarged Prostate
GlaxoSmithKline has received a new indication for Avodart (dutasteride) in combination with the alpha blocker tamsulosin for the treatment of symptomatic enlarged prostate, a disease affecting half of all men over age 50.
Data Support Prednisolone Use For Gout
A short course of a corticosteroid could supplant nonsteroidal anti-inflammatory drugs (NSAIDs) as the medication of choice to treat gout, Dutch researchers suggest.
Fixed-Dose Combination Tablet Approved for Type 2 Diabetes
Sciele Pharma, Inc., of Atlanta and Novo Nordisk Inc., of Denmark, have announced approval for PrandiMet (repaglinide and metformin HCl) tablets, the first and only fixed-dose combination of the fast-acting secretagogue replaglinide (also called Prandin) and the insulin sensitizer metformin for the treatment of type 2 diabetes.
- Loading...
Loading...
Next post in FDA News
Loading... 
Loading...